Literature DB >> 34173918

Transmembrane Protease TMPRSS4 Promotes the Formation and Development of Mismatch Repair Deficient Colon Cancer Liver Metastasis.

Y S Yang1, D Wen1, X F Zhao2.   

Abstract

We studied metastasis-promoting effect of transmembrane protease TMPRSS4 on mismatch repair (MMR)-deficient colorectal cancer liver metastasis in BALB/c nude mouse model. Histomorphological and histopathological studies showed that the number of liver metastases in the study group were significantly higher than that in the control group (p<0.05). The expression of TMPRSS4 mRNA and protein in the study group were obviously higher than in the control group (p<0.05). These findings suggest that TMPRSS4 possesses a metastasis-promoting effect and its low expression can effectively block the progression of MMR-deficient colon cancer liver metastasis.

Entities:  

Keywords:  BALB/c nude mouse; DNA mismatch repair deficiencies; TMPRSS4; colon cancer liver metastasis; metastasis-promoting effect

Mesh:

Substances:

Year:  2021        PMID: 34173918     DOI: 10.1007/s10517-021-05203-6

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  11 in total

1.  MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2).

Authors:  Nicola Valeri; Pierluigi Gasparini; Chiara Braconi; Alessio Paone; Francesca Lovat; Muller Fabbri; Khlea M Sumani; Hansjuerg Alder; Dino Amadori; Tushar Patel; Gerard J Nuovo; Richard Fishel; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-15       Impact factor: 11.205

2.  Phenotypes of invasion in sporadic colorectal carcinomas related to aberrations of the adenomatous polyposis coli (APC ) gene.

Authors:  F Prall; V Weirich; C Ostwald
Journal:  Histopathology       Date:  2007-02       Impact factor: 5.087

3.  A novel transmembrane serine protease (TMPRSS3) overexpressed in pancreatic cancer.

Authors:  C Wallrapp; S Hähnel; F Müller-Pillasch; B Burghardt; T Iwamura; M Ruthenbürger; M M Lerch; G Adler; T M Gress
Journal:  Cancer Res       Date:  2000-05-15       Impact factor: 12.701

4.  TMPRSS4 induces invasion and epithelial-mesenchymal transition through upregulation of integrin alpha5 and its signaling pathways.

Authors:  Semi Kim; Hee Young Kang; Eun-Hee Nam; Myung-Sook Choi; Xue-Feng Zhao; Chang Soo Hong; Jung Weon Lee; Jae Hyuk Lee; Young-Kyu Park
Journal:  Carcinogenesis       Date:  2010-01-29       Impact factor: 4.944

5.  Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer.

Authors:  Daniel J Sargent; Silvia Marsoni; Genevieve Monges; Stephen N Thibodeau; Roberto Labianca; Stanley R Hamilton; Amy J French; Brian Kabat; Nathan R Foster; Valter Torri; Christine Ribic; Axel Grothey; Malcolm Moore; Alberto Zaniboni; Jean-Francois Seitz; Frank Sinicrope; Steven Gallinger
Journal:  J Clin Oncol       Date:  2010-05-24       Impact factor: 44.544

6.  Global cancer statistics, 2012.

Authors:  Lindsey A Torre; Freddie Bray; Rebecca L Siegel; Jacques Ferlay; Joannie Lortet-Tieulent; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-02-04       Impact factor: 508.702

7.  The role of miRNA-21 and epithelial mesenchymal transition (EMT) process in colorectal cancer.

Authors:  Anelisa Jaca; Padmini Govender; Michael Locketz; Richard Naidoo
Journal:  J Clin Pathol       Date:  2016-09-26       Impact factor: 3.411

Review 8.  Genomic and epigenetic instability in colorectal cancer pathogenesis.

Authors:  William M Grady; John M Carethers
Journal:  Gastroenterology       Date:  2008-09-04       Impact factor: 22.682

9.  Overexpression of TMPRSS4 promotes tumor proliferation and aggressiveness in breast cancer.

Authors:  Xiao-Mei Li; Wen-Lou Liu; Xu Chen; Ya-Wen Wang; Duan-Bo Shi; Hui Zhang; Ran-Ran Ma; Hai-Ting Liu; Xiang-Yu Guo; Feng Hou; Ming Li; Peng Gao
Journal:  Int J Mol Med       Date:  2017-02-17       Impact factor: 4.101

10.  Anti-cancer activity of the novel 2-hydroxydiarylamide derivatives IMD-0354 and KRT1853 through suppression of cancer cell invasion, proliferation, and survival mediated by TMPRSS4.

Authors:  Solbi Kim; Dongjoon Ko; Yunhee Lee; Seonghui Jang; Younghoon Lee; Ill Young Lee; Semi Kim
Journal:  Sci Rep       Date:  2019-07-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.